[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100335688":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":23,"locations":28,"responsibleParty":47,"collaborators":10,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":51,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"University Hospital, Montpellier","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Diagnostic Test: Identification of subgroups of patients with",null,[12],"Diagnostic Test: Identification of subgroups of patients with early AD with risk of progression",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DIAGNOSTIC_TEST","Identification of subgroups of patients with early AD with risk of progression","Clinical examination with questionnaires, Biological collection, Imaging (radiography, densitometry, ultrasound, and MRI)",[9],[20],{"name":21,"affiliation":5,"role":22},"Yves-Marie PERS, MD","PRINCIPAL_INVESTIGATOR",[24],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","+33 618993804","ympers2000@yahoo.fr",[29],{"facility":30,"status":31,"city":32,"state":10,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Department of Rheumatology, CHU Montpellier","RECRUITING","Montpellier","34295","France","FR",{"type":37,"coordinates":38},"Point",[39,40],3.87635,43.61093,{"lat":40,"lon":39},[43],{"name":44,"role":25,"phone":45,"phoneExt":10,"email":46},"Michelle MOYA, CRA","+33 609980911","michellemoya@orange.fr",{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100335688","a-prospective-cohort-study-of-patients-suffering-from-hand-osteoarthritis-symptoms-100335688",false,"NCT03650673","A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis Symptoms","A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis","COARDIG","Inclusion Criteria:\n\n\\- Early digital osteoarthritis must combine the clinical AND radiological definition.\n\nClinical definition:\n\nAt least one of the following 4 criteria: Pain or stiffness or swelling or deformity of a digital joint (IPP and \u002F or IPD) A breach of at least one PPI and \u002F or IPD Age under 60 at the time of the first symptoms Clinical symptoms have been changing for less than 3 years\n\nRadiographic definition:\n\nThe presence of the achievement of at least one PPI and \u002F or IPD. Presence of at least two of the following three criteria: pinching, marginal subchondral condensation, marginal osteophyte Erosion on radiography is not an exclusion criteria\n\n\\- Consent form signed\n\nExclusion criteria:\n\n* patients suffering from rheumatoid arthritis, rheumatoid psoriasis or any other inflammatory rheumatism\n* patients suffering from metabolic diseasis such as gout, hemochromatosis, Wilson's disease; or from congenital disease such as displasie, osteogenesis,\n* Presence of advanced radiographic osteoarthritis based in Kellgreen Lawrence score (=4) in one joint among the 10 previous sites.\n* Not able to provide a sample of blood for any reasons\n* MRI contraindication\n* Being in exclusion period determined by another previous study\n* Subject non affiliated to social insurance\n* Pregnant or lactating women\n* Vulnerable people based in L1121-5 article of CSP\n* Elderly subject or protected subjects disabled to give their consent\n* Subjects private of freedom by court or administrative order","ALL","18 Years","60 Years",{"count":61,"type":62},150,"ESTIMATED","INTERVENTIONAL",[65],"NA","The late-stage forms of degenerative osteoarthritis (OA) are very debilitating and less affordable to therapy. The main objective is to identify early onset symptoms of hand OA patients through imaging techniques (such as ultrasound and MRI). Our primary endpoint is to specify patients with high risk of radiological profression (X-ray).",[68],"Hand Osteoarthritis",[70,71,72,73],"Hand osteoarthritis","Prospective cohort","Cartilage","Mobility","2025-09-24",{"date":76,"type":77},"2025-09-30","ACTUAL",{"date":79,"type":77},"2019-07-15",{"date":81,"type":62},"2028-10-31",{"name":5,"class":6},1]